Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Tuesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE stock opened at $0.00 on Tuesday. The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.04. The stock has a market cap of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.91.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.